CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Tactile Systems - TCMD CFD

    13.22
    1.46%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.07
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Tactile Systems Technology Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 13.03
    Open* 12.92
    1-Year Change* 24.23%
    Day's Range* 12.92 - 13.26
    52 wk Range 8.18-26.11
    Average Volume (10 days) 643.20K
    Average Volume (3 months) 9.58M
    Market Cap 297.24M
    P/E Ratio 11.81
    Shares Outstanding 23.50M
    Revenue 270.67M
    EPS 1.07
    Dividend (Yield %) N/A
    Beta 1.34
    Next Earnings Date Feb 19, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 6, 2023 13.03 -0.02 -0.15% 13.05 13.37 12.94
    Dec 5, 2023 13.04 -0.47 -3.48% 13.51 13.65 12.91
    Dec 4, 2023 13.64 0.16 1.19% 13.48 13.85 13.08
    Dec 1, 2023 13.73 0.45 3.39% 13.28 13.84 13.17
    Nov 30, 2023 13.31 -0.69 -4.93% 14.00 14.00 13.11
    Nov 29, 2023 13.99 -0.06 -0.43% 14.05 14.51 13.91
    Nov 28, 2023 13.97 -0.10 -0.71% 14.07 14.22 13.50
    Nov 27, 2023 14.00 0.18 1.30% 13.82 14.30 13.77
    Nov 24, 2023 13.76 0.26 1.93% 13.50 14.27 13.47
    Nov 22, 2023 13.43 0.70 5.50% 12.73 13.57 12.68
    Nov 21, 2023 12.62 -0.10 -0.79% 12.72 12.85 12.18
    Nov 20, 2023 12.61 1.21 10.61% 11.40 12.67 11.36
    Nov 17, 2023 11.47 0.14 1.24% 11.33 11.73 11.33
    Nov 16, 2023 11.34 0.11 0.98% 11.23 11.37 10.88
    Nov 15, 2023 11.31 0.47 4.34% 10.84 11.55 10.84
    Nov 14, 2023 10.99 0.23 2.14% 10.76 11.26 10.59
    Nov 13, 2023 10.71 -0.01 -0.09% 10.72 11.03 10.43
    Nov 10, 2023 10.67 0.06 0.57% 10.61 10.77 10.34
    Nov 9, 2023 10.63 0.57 5.67% 10.06 10.97 10.01
    Nov 8, 2023 9.96 -0.01 -0.10% 9.97 10.46 9.78

    Tactile Systems Events

    Time (UTC) Country Event
    Monday, February 19, 2024

    Time (UTC)

    13:30

    Country

    US

    Event

    Q4 2023 Tactile Systems Technology Inc Earnings Release
    Q4 2023 Tactile Systems Technology Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 246.785 208.057 187.13 189.492 143.751
    Revenue 246.785 208.057 187.13 189.492 143.751
    Cost of Revenue, Total 126.658 111.289 97.528 90.108 75.101
    Gross Profit 120.127 96.768 89.602 99.384 68.65
    Total Operating Expense 259.543 209.819 189.558 178.994 140.761
    Selling/General/Admin. Expenses, Total 111.365 92.132 84.366 83.712 60.371
    Research & Development 7.088 5.659 5.264 5.174 5.289
    Operating Income -12.758 -1.762 -2.428 10.498 2.99
    Other, Net -2.715 -0.531 0.167 0.631 0.486
    Net Income Before Taxes -15.473 -2.293 -2.261 11.129 3.476
    Net Income After Taxes -17.866 -11.811 -0.62 10.971 6.623
    Net Income Before Extra. Items -17.866 -11.811 -0.62 10.971 6.623
    Net Income -17.866 -11.811 -0.62 10.971 6.623
    Total Adjustments to Net Income 0
    Income Available to Common Excl. Extra. Items -17.866 -11.811 -0.62 10.971 6.623
    Income Available to Common Incl. Extra. Items -17.866 -11.811 -0.62 10.971 6.623
    Dilution Adjustment
    Diluted Net Income -17.866 -11.811 -0.62 10.971 6.623
    Diluted Weighted Average Shares 20.068 19.7195 19.3469 19.6411 19.3476
    Diluted EPS Excluding Extraordinary Items -0.89027 -0.59895 -0.03205 0.55857 0.34232
    Diluted Normalized EPS -0.89027 -0.59895 0.04859 0.55857 0.34232
    Total Extraordinary Items
    Unusual Expense (Income) 2.4
    Depreciation / Amortization 14.432 0.739
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 68.339 58.846 73.9 65.262 59.645
    Revenue 68.339 58.846 73.9 65.262 59.645
    Cost of Revenue, Total 34.198 31.693 34.156 33.387 29.798
    Gross Profit 34.141 27.153 39.744 31.875 29.847
    Total Operating Expense 66.281 62.652 66.05 66.882 63.732
    Selling/General/Admin. Expenses, Total 29.039 27.421 28.157 27.921 30.34
    Research & Development 1.833 2.233 2.139 1.581 1.849
    Operating Income 2.058 -3.806 7.85 -1.62 -4.087
    Other, Net -0.838 -0.993 -0.95 -0.736 -0.573
    Net Income Before Taxes 1.22 -4.799 6.9 -2.356 -4.66
    Net Income After Taxes -0.1 -1.886 4.621 -2.279 -4.64
    Net Income Before Extra. Items -0.1 -1.886 4.621 -2.279 -4.64
    Net Income -0.1 -1.886 4.621 -2.279 -4.64
    Income Available to Common Excl. Extra. Items -0.1 -1.886 4.621 -2.279 -4.64
    Income Available to Common Incl. Extra. Items -0.1 -1.886 4.621 -2.279 -4.64
    Diluted Net Income -0.1 -1.886 4.621 -2.279 -4.64
    Diluted Weighted Average Shares 23.3525 21.2838 20.206 20.1399 20.0248
    Diluted EPS Excluding Extraordinary Items -0.00428 -0.08861 0.22869 -0.11316 -0.23171
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.00428 -0.08861 0.22869 -0.11316 -0.23171
    Depreciation / Amortization 1.211 1.305 1.598 3.993 1.745
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 119.763 113.547 123.613 108.335 84.961
    Cash and Short Term Investments 38.059 40.711 58.563 53.381 45.885
    Cash & Equivalents 21.929 28.229 47.855 22.77 20.099
    Short Term Investments 16.13 12.482 10.708 30.611 25.786
    Total Receivables, Net 54.826 49.478 43.849 33.444 26.125
    Accounts Receivable - Trade, Net 54.826 49.478 43.849 33.444 24.332
    Total Inventory 23.124 19.217 18.563 19.059 11.189
    Prepaid Expenses 3.754 4.141 2.638 2.451 1.762
    Other Current Assets, Total
    Total Assets 254.996 244.27 174.087 151.752 107.071
    Property/Plant/Equipment, Total - Net 27.399 30.734 27.089 23.293 4.81
    Property/Plant/Equipment, Total - Gross 38.184 39.777 34.465 28.604 10.45
    Accumulated Depreciation, Total -10.785 -9.043 -7.376 -5.311 -5.64
    Intangibles, Net 50.375 54.081 1.68 5.312 5.339
    Note Receivable - Long Term 23.061 12.847 9.433 4.184 1.884
    Other Long Term Assets, Total 3.335 1.998 12.272 10.628 10.077
    Total Current Liabilities 64.33 34.461 26.714 21.428 16.076
    Accounts Payable 9.984 5.023 4.197 3.843 5.11
    Accrued Expenses 28.84 19.907 18.017 16.05 10.201
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 22.538 6.571 4.5 1.535 0.765
    Total Liabilities 133.596 116.043 49.337 39.157 17.801
    Total Long Term Debt 45.895 51.79 0 0 0
    Other Liabilities, Total 23.371 29.76 22.623 17.729 1.725
    Total Equity 121.4 128.227 124.75 112.595 89.27
    Redeemable Preferred Stock 0 0 0 0
    Common Stock 0.02 0.02 0.019 0.019 0.019
    Additional Paid-In Capital 131.001 119.962 104.675 91.874 79.554
    Retained Earnings (Accumulated Deficit) -9.621 8.245 20.056 20.676 9.705
    Other Equity, Total 0.026 -0.008
    Total Liabilities & Shareholders’ Equity 254.996 244.27 174.087 151.752 107.071
    Total Common Shares Outstanding 20.2527 19.8778 19.4927 19.1527 18.6311
    Treasury Stock - Common 0
    Goodwill, Net 31.063 31.063
    Current Port. of LT Debt/Capital Leases 2.968 2.96
    Long Term Debt 45.895 51.79
    Deferred Income Tax 0 0.032
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 151.69 149.558 145.433 119.763 116.796
    Cash and Short Term Investments 79.639 76.431 68.792 38.059 38.478
    Cash & Equivalents 66.036 63.212 55.011 21.929 23.426
    Short Term Investments 13.603 13.219 13.781 16.13 15.052
    Total Receivables, Net 43.879 48.332 51.751 54.826 51.814
    Accounts Receivable - Trade, Net 43.879 46.553 51.02 54.826 51.814
    Total Inventory 23.498 20.315 20.014 23.124 23.02
    Prepaid Expenses 4.674 4.48 4.876 3.754 3.484
    Total Assets 293.307 273.728 275.501 254.996 248.526
    Property/Plant/Equipment, Total - Net 24.789 25.812 26.288 27.399 28.652
    Intangibles, Net 47.628 48.559 49.465 50.375 51.308
    Note Receivable - Long Term 14.636 15.43 19.983 23.061 17.703
    Other Long Term Assets, Total 23.501 3.306 3.269 3.335 3.004
    Total Current Liabilities 45.618 48.52 51.404 64.33 55.661
    Accounts Payable 6.402 9.296 9.59 9.984 11.171
    Accrued Expenses 22.707 21.495 20.574 28.84 23.014
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 13.553 14.761 18.272 22.538 18.508
    Total Liabilities 110.477 114.965 119.339 133.596 134.129
    Total Long Term Debt 43.592 44.436 45.166 45.895 46.625
    Other Liabilities, Total 21.267 22.009 22.769 23.371 31.794
    Total Equity 182.83 158.763 156.162 121.4 114.397
    Common Stock 0.023 0.023 0.023 0.02 0.02
    Additional Paid-In Capital 172.115 170.347 167.646 131.001 128.619
    Retained Earnings (Accumulated Deficit) 10.692 -11.607 -11.507 -9.621 -14.242
    Total Liabilities & Shareholders’ Equity 293.307 273.728 275.501 254.996 248.526
    Total Common Shares Outstanding 23.4976 23.4583 23.2351 20.2527 20.1557
    Redeemable Preferred Stock 0 0 0 0
    Goodwill, Net 31.063 31.063 31.063 31.063 31.063
    Current Port. of LT Debt/Capital Leases 2.956 2.968 2.968 2.968 2.968
    Long Term Debt 43.592 44.436 45.166 45.895 46.625
    Deferred Income Tax 0 0.049
    Other Equity, Total 0
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -17.866 -11.811 -0.62 10.971 6.623
    Cash From Operating Activities 5.209 2.631 2.794 2.51 9.007
    Cash From Operating Activities 6.268 3.681 2.794 3.538 3.635
    Deferred Taxes -0.032 10.23 -1.233 -0.146 -6.182
    Non-Cash Items 21.47 9.993 14.612 10.672 10.512
    Cash Taxes Paid 0.044 1.593 0.543 0.344 2.883
    Cash Interest Paid 2.186 0.13 0 0 0.009
    Changes in Working Capital -4.631 -9.462 -12.759 -22.525 -5.581
    Cash From Investing Activities -1.909 -82.184 20.179 -2.335 -14.726
    Capital Expenditures -1.92 -2.355 -2.291 -5.988 -9.546
    Other Investing Cash Flow Items, Total 0.011 -79.829 22.47 3.653 -5.18
    Cash From Financing Activities -9.6 59.927 2.112 2.496 1.85
    Financing Cash Flow Items -5.039 -1.361 -1.854 -3.391 -2.379
    Total Cash Dividends Paid
    Issuance (Retirement) of Stock, Net 1.439 6.288 3.966 5.887 4.229
    Issuance (Retirement) of Debt, Net -6 55
    Net Change in Cash -6.3 -19.626 25.085 2.671 -3.869
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -1.886 -17.866 -22.487 -20.208 -15.568
    Cash From Operating Activities -0.502 5.209 1.354 -0.9 -3.206
    Cash From Operating Activities 1.629 6.268 4.67 3.015 1.507
    Deferred Taxes 0 -0.032 0.017 0.094 0.115
    Non-Cash Items 2.686 21.47 18.599 12.671 8.678
    Cash Taxes Paid 0.006 0.044 0.029 0.028 0.012
    Changes in Working Capital -2.931 -4.631 0.555 3.528 2.062
    Cash From Investing Activities -0.291 -1.909 -1.844 -0.416 -0.175
    Capital Expenditures -0.291 -1.92 -1.844 -0.416 -0.175
    Other Investing Cash Flow Items, Total 0.011
    Cash From Financing Activities 33.875 -9.6 -4.313 -3.563 -3.698
    Financing Cash Flow Items 0 -5.039 -0.039 -0.039 -0.039
    Issuance (Retirement) of Stock, Net 34.625 1.439 0.976 0.976 0.091
    Net Change in Cash 33.082 -6.3 -4.803 -4.879 -7.079
    Issuance (Retirement) of Debt, Net -0.75 -6 -5.25 -4.5 -3.75
    Cash Interest Paid 0.927 2.186 1.433 0.448 0.413

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Tactile Systems Company profile

    About Tactile Systems Technology Inc

    Tactile Systems Technology, Inc. is a medical technology company focused on developing medical devices for the treatment of chronic diseases. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. It is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. It possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Tactile Systems Technology Inc revenues increased 11% to $208.1M. Net loss increased from $620K to $11.8M. Revenues reflect Flexitouch system segment increase of 8% to $176.2M, Entre/Actitouch systems segment increase of 15% to $26.7M. Higher net loss reflects Sales and marketing - Balancing value increase of 11% to $82.7M (expense), Stock-based Compensation in SGA increase of 13% to $5.4M (expense).

    Industry: Medical Equipment

    1331 Tyler St NE Ste 200
    MINNEAPOLIS
    MINNESOTA 55413-1638
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    BTC/USD

    43,231.80 Price
    -1.380% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    US100

    16,000.50 Price
    +1.320% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    XRP/USD

    0.65 Price
    +0.970% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Oil - Crude

    69.79 Price
    +0.510% 1D Chg, %
    Long position overnight fee -0.0206%
    Short position overnight fee -0.0013%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading